Predictive analysis of exhaled nitric oxide, FeNO and Cano for postoperative complications of lung cancer

Predictive analysis of exhaled nitric oxide FeNO and CaNO for postoperative complications of lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037539

Enrollment

Unknown

Registered

2020-08-28

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Postoperative complications group:no

Without postoperative complications group:Nil

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Lung cancer patients; (2) Type of operation: lobectomy (minimally invasive surgery) (3) The patients who could tolerate pulmonary function test and FeNO + Cano test and had good compliance.

Exclusion criteria

Exclusion criteria: (1) Incomplete resection was performed; (2) The researchers judged the patients who were not suitable for the trial; (3) Severe liver and kidney dysfunction; (4) Severe muscle disease or mental disease; (5) Combined with other malignant tumors except lung cancer; (6) He received corticosteroid treatment within 3 months.

Design outcomes

Primary

Measure	Time frame
Exhaled nitric oxide;	—

Countries

China

Contacts

Public ContactWANG WEIMIN

Shanghai Chest Hospital, Shanghai Jiaotong University

13817680693@139.com+86 13817680693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026